Skip to main content
In Vitro-Selected Nanobody-Based Cellular Therapy Targeting CD72 for Treatment of Refractory B-Cell Malignancies.
DNA Methylation As a Biomarker of Outcome in JMML: An International Effort Towards Clinical Implementation.
A Phase 3 Study of Eltrombopag Vs. Standard First-Line Management for Newly Diagnosed Immune Thrombocytopenia in Children.
Role of Disease Mechanism in Hematopoietic Cell Transplantation Outcomes for Hemophagocytic Lymphohistiocytosis.
Reduced Toxicity Conditioning for Non-Malignant Hematopoietic Cell Transplants.
Calming the storm in HLH.
In ALD, I feel the need for speed.
Single-cell RNA-Seq of follicular lymphoma reveals malignant B-cell types and coexpression of T-cell immune checkpoints.
Phase I Study of the Selinexor in Relapsed/Refractory Childhood Acute Leukemia.
Germline GAB2 Mutations in Childhood Acute Lymphoblastic Leukemia.